An official website of the United States government
Home
Name
DCVax-Lung
Alternate Names
None
Abbreviations
None
Category
Other therapy
Subcategory
None
NSC Number
None
Primary Site
Lung cancer
Histology
None
Remarks
1/7/18: This agent has not yet received FDA approval. Code in Other Treatment.
Phase II NSCLC Dendritic cell based immunotherapy.
Phase II NSCLC Dendritic cell based immunotherapy.
Coding
Please see remarks for additional information
